David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$436M |
| 2 |
AbbVie
ABBV
|
+$407M |
| 3 |
Johnson & Johnson
JNJ
|
+$295M |
| 4 |
Gilead Sciences
GILD
|
+$267M |
| 5 |
Starbucks
SBUX
|
+$230M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$407M |
| 2 |
Booking.com
BKNG
|
+$400M |
| 3 |
Citigroup
C
|
+$314M |
| 4 |
SHPG
Shire pic
SHPG
|
+$276M |
| 5 |
PayPal
PYPL
|
+$257M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.04% |
| 2 | Healthcare | 13.44% |
| 3 | Consumer Discretionary | 13.38% |
| 4 | Financials | 7.19% |
| 5 | Industrials | 6.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
851
MSC Industrial Direct
MSM
$6.66B
| $14.9M | 0.02% |
180,093
-123,582
| -41% | -$10.2M |
|
852
Cirrus Logic
CRUS
$5.6B
| $14.9M | 0.02% |
353,628
+15,337
| +5% | +$592K |
|
853
Essent Group
ESNT
$6.15B
| $14.8M | 0.02% |
340,447
-119,533
| -26% | -$4.92M |
|
854
CALL
Simon Property Group
SPG
$71.4B
| $14.7M | 0.02% |
80,800
+70,800
| +708% | +$12.6M |
|
855
Americold
COLD
$4.31B
| $14.7M | 0.02% |
481,326
+225,308
| +88% | +$6.48M |
|
856
Patterson-UTI
PTEN
$4.52B
| $14.7M | 0.02% |
1,046,019
+51,138
| +5% | +$671K |
|
857
Avnet
AVT
$7.08B
| $14.6M | 0.02% |
337,418
-288,017
| -46% | -$12.2M |
|
858
New Oriental
EDU
$8.97B
| $14.6M | 0.02% |
162,432
-238,741
| -60% | -$18M |
|
|
VRN
859
DELISTED
Veren
VRN
| $14.6M | 0.02% |
4,509,591
+3,217,276
| +249% | +$9.91M |
|
|
FLOW
860
DELISTED
SPX FLOW, Inc.
FLOW
| $14.6M | 0.02% |
458,023
-19,905
| -4% | -$654K |
|
|
INXN
861
DELISTED
Interxion Holding N.V.
INXN
| $14.6M | 0.02% |
218,647
-255,731
| -54% | -$15.8M |
|
|
RTN
862
CALL
DELISTED
Raytheon Company
RTN
| $14.6M | 0.02% |
+80,000
| New | +$13.9M |
|
|
JOYY
863
PUT
JOYY Inc
JOYY
$3.7B
| $14.5M | 0.02% |
173,000
+900
| +0.5% | +$65.4K |
|
|
SFLY
864
DELISTED
Shutterfly, Inc.
SFLY
| $14.5M | 0.02% |
355,877
-271,091
| -43% | -$11.9M |
|
865
PUT
Shopify
SHOP
$193B
| $14.4M | 0.02% |
696,000
-1,554,000
| -69% | -$27.4M |
|
866
Pembina Pipeline
PBA
$28.3B
| $14.4M | 0.02% |
391,000
-259,574
| -40% | -$9.19M |
|
867
Douglas Emmett
DEI
$2B
| $14.3M | 0.02% |
354,798
-602,381
| -63% | -$22.9M |
|
868
FMC
FMC
$1.41B
| $14.3M | 0.02% |
186,650
-332,846
| -64% | -$24.4M |
|
869
Boston Beer
SAM
$1.95B
| $14.3M | 0.02% |
48,612
-4,573
| -9% | -$1.25M |
|
|
LOGM
870
DELISTED
LogMein, Inc.
LOGM
| $14.3M | 0.02% |
178,882
+105,067
| +142% | +$8.98M |
|
871
PUT
Lowe's Companies
LOW
$122B
| $14.3M | 0.02% |
130,800
-115,300
| -47% | -$11.5M |
|
872
Cummins
CMI
$78.7B
| $14.3M | 0.02% |
90,486
+27,832
| +44% | +$4.18M |
|
873
Performance Food Group
PFGC
$16.6B
| $14.3M | 0.02% |
359,680
-71,687
| -17% | -$2.63M |
|
874
Stratasys
SSYS
$670M
| $14.3M | 0.02% |
598,227
+405,421
| +210% | +$9.76M |
|
875
Groupon
GRPN
$798M
| $14.2M | 0.02% |
200,625
+26,522
| +15% | +$1.87M |
|
Similar funds
David Shaw's Q1 2019 Portfolio in Review
As of Q1 2019, David Shaw held 4,169 positions worth $77.4B, up 6.6% from $72.6B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
David Shaw withdrew a net $6.74B in Q1 2019, closing 617 positions and reducing 1,599 holdings. Its most notable exit was Shire pic, an estimated $276M position sold in full.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, David Shaw opened a new position in Lyft worth $159M.
- David Shaw's largest Q1 2019 buy was Lyft: 2,245,851 shares worth $159M.
- David Shaw added most to Pfizer in Q1 2019, an estimated $436M increase.
- David Shaw's biggest Q1 2019 reduction was Bristol-Myers Squibb, cutting an estimated $407M.
- David Shaw fully exited Shire pic in Q1 2019, selling an estimated $276M.
- David Shaw's ten largest holdings make up 9% of its $77.4B portfolio in Q1 2019.
- David Shaw opened 447 new positions and closed 617 in Q1 2019.
- David Shaw's portfolio value rose 6.6% quarter-over-quarter to $77.4B.
Based on D.E. Shaw & Co's 13F filing for Q1 2019, filed 15 May 2019.